# Efficacy Study of Intravenous Sodium Valproate in Addition to First Line Anti Epileptic Treatment of Generalized Convulsive Status Epilepticus.

> **NCT01791868** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 245 (actual)

## Conditions studied

- Generalized Convulsive Status Epilepticus
- Intensive Care Unit

## Interventions

- **DRUG:** Intravenous Sodium Valproate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01791868
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2018-07
- **Final completion:** 2018-10
- **Target enrollment:** 245 (ACTUAL)
- **Last updated:** 2018-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01791868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01791868, "Efficacy Study of Intravenous Sodium Valproate in Addition to First Line Anti Epileptic Treatment of Generalized Convulsive Status Epilepticus.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01791868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*